SMS Pharmaceuticals Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakhs)
SMS Pharmaceuticals Ltd · Outcome · 04 Nov 2026, 6:56 pm
SMS Pharmaceuticals Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakhs) ■ Revenue: 31,609 (+30.4% YoY | +52.7% QoQ) ■ EBITDA: 6,766 (+39.9% YoY | +65.2% QoQ) ■ EBITDA Margin (%): 21.4 (+145 bps YoY | +162 bps QoQ) ■ PAT: 3,985 (+57.4% YoY | +90.6% QoQ) ■ EPS (INR): 4.26 (+50.0% YoY | +91.0% QoQ)
Original exchange filing (PDF)
More announcements from SMS Pharmaceuticals Ltd
- Earnings Call Transcript · 10 Nov 2026
- Investors Meet Audio Recording · 05 Nov 2026
- Press release on Financial Results · 05 Nov 2026
- Investor Presentation for quarter and half year ended September 30, 2026 · 04 Nov 2026
- Financial results and change in Company Secretary · 04 Nov 2026
- SMS Pharmaceuticals Limited has informed the Exchange about General Updates · 04 Nov 2026
- Change in Management_Company Secretary · 04 Nov 2026
- SMS Pharmaceuticals Limited has informed the Exchange about Change in Company Secretary/Compliance Officer · 04 Nov 2026
